The GLOW Stack Explained: BPC-157, TB-500 & GHK-Cu
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. The "GLOW" stack is a label used in the research-peptide community for a combination of three frequently studied compounds: BPC-157, TB-500, and GHK-Cu. This article describes what each component is, why researchers study it, and how the grouping is framed in laboratory and educational contexts. It does not describe or endorse any use in humans or animals.
What the GLOW stack combines
The GLOW grouping brings together three distinct research compounds that each appear in published tissue-repair and regeneration literature. BPC-157 is a synthetic pentadecapeptide derived from a sequence found in gastric juice. TB-500 is a synthetic fragment related to the protein thymosin beta-4. GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) complexed with copper. The stack is discussed by researchers as a way to study several regeneration-associated pathways side by side rather than in isolation. For background on how investigators catalog and differentiate these compounds, see our research finder.
BPC-157: why it is studied
In published research, BPC-157 has been examined in animal and in vitro models of soft-tissue healing, with particular attention to angiogenesis, the formation of new blood vessels. Investigators have correlated its effects with modulation of vascular endothelial growth factor (VEGF) expression in muscle and tendon healing models. Researchers study BPC-157 primarily as a tool for understanding how peptide signaling intersects with the healing cascade. All such work to date is preclinical and conducted in laboratory settings; no conclusions about human outcomes are drawn here.
TB-500 and GHK-Cu: complementary research targets
TB-500 is studied as a synthetic peptide related to thymosin beta-4, a protein that researchers associate with actin regulation, cell migration, and tissue-repair signaling in experimental models. GHK-Cu, by contrast, is investigated for its role in skin and connective-tissue biology. In published research, GHK has been described as a modulator of multiple cellular pathways involved in collagen and glycosaminoglycan turnover and in attracting repair-associated cells to injury sites in animal models. Because the three compounds map onto overlapping but distinct regeneration pathways, the GLOW grouping is framed by researchers as a way to explore those pathways together in controlled laboratory study. Proper handling matters for reproducibility; our guide on how to reconstitute peptides covers laboratory preparation practices.
How the GLOW stack relates to other research stacks
The GLOW stack is one of several named combinations discussed in the research community. Others include the KLOW stack and the Wolverine stack, which overlap with GLOW in some components and differ in others. Comparing these groupings helps researchers reason about which pathways a given combination is designed to probe. For side-by-side context, see our companion explainers on the KLOW stack and the Wolverine stack. Note that some discussion of these stacks online consists of unverified anecdotal reports, not controlled findings, and BioRegen does not make or endorse any claims based on them.
Frequently asked questions
What does "GLOW stack" mean?
It is a community label for a research combination of BPC-157, TB-500, and GHK-Cu. The term is descriptive of the grouping studied in laboratory contexts and does not imply any approved application.
Why are these three compounds grouped together?
Each is associated in published research with different but overlapping aspects of tissue-repair and regeneration biology, so researchers study them together to compare and contrast those pathways.
Are these compounds approved for use?
No. None of the compounds referenced here is approved for human or veterinary use. They are offered and discussed strictly for laboratory and educational research.
Selected research references
- Pickart L, et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. https://doi.org/10.1155/2015/648108
Reference metadata sourced via PubMed.
To go deeper into laboratory methodology, explore the BioRegen research guide and use code RESEARCH10 for 10% off your first order. You can also browse the related Regenesis research category for the compounds discussed above.
This content is provided for laboratory and educational research only. No compound referenced is approved for human or veterinary use, no therapeutic claims are made, and nothing here is medical advice.